Gw Pharmaceuticals Plc Revenue per Employee (GWPH), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Gw Pharmaceuticals Plc  (NASDAQ: GWPH)
 

Gw Pharmaceuticals Plc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 26.39% in the first quarter 2021, year on year to cumulative value of $559 million, Gw Pharmaceuticals Plc's revenue per employee grew on a trailing twelve months basis to $ 629,547. The productivity of Gw Pharmaceuticals Plc's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 115 other companies have achieved higher revenue per employee. While Gw Pharmaceuticals Plc's total ranking has deteriorated compared to the previous quarter from 0 to 1388. Gw Pharmaceuticals Plc has 888 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GWPH Revenue per Employee (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter
Y / Y Revenue Change 26.39 % 35.89 % 50.66 % 68.38 % 207.37 %
Sales per Employee (TTM) $ 629,547 593,699 549,616 497,722 442,250
GWPH's Total Ranking # 1388 # 0 # 0 # 0 # 0
Seq. Revenue Change 2.86 % 8.15 % 12.99 % 0.55 % 10.6 %

GWPH Company Profile >> Back to GWPH Efficiency Comparisons >> Compare GWPH Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 68
Healthcare Sector # 116
Overall Market # 1388

Revenue per Employee Statistics
High Average Low
$ 549,616 $ 429,539 $ 350,599
(Sep 30 2020)   (Dec 31 2020)



Financial Statements
Gw Pharmaceuticals Plc's Revenue MRQ $ 152 Millions Visit GWPH's Income Statement
Gw Pharmaceuticals Plc's Revenues TTM $ 559 Millions Visit GWPH's aggregate revenue growth
What are GWPH's Sales? Visit GWPH's Sales by Segment




Other Ratios
Gw Pharmaceuticals Plc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
GWPH's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for GWPH's Competitors
Revenue per Employee for GWPH's Suppliers
Revenue per Employee for GWPH's Customers

You may also want to know
GWPH's Sales Growth Rates GWPH's Pe Price to earnings ratio GWPH's Receivables Turnover Ratio GWPH's Stock Quote
GWPH's Net Income Growth Rates GWPH's Ps Price to Sales ratio GWPH's Sales per Employee GWPH's Asset Turnover Ratio
GWPH's Net Margin GWPH's Pb Price to Book ratio GWPH's Financial Strength Ratios GWPH's Dividend Payout Ratio
Date modified: 2026-09-08T15:10:15+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2021, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2021Number of Employees Mar 31 2021
Palvella Therapeutics Inc   1,092,931.03 $ 31.695  Million 29 
G1 Therapeutics Inc   1,081,872.73 $ 59.503  Million 55 
United Therapeutics Corporation  1,075,785.71 $ 1,506.100  Million 1,400 
Exicure Inc   1,053,375.00 $ 8.427  Million 8 
Editas Medicine Inc   1,051,816.09 $ 91.508  Million 87 
Agenus Inc  1,046,432.10 $ 84.761  Million 81 
Titan Pharmaceuticals Inc   1,046,000.00 $ 4.184  Million 4 
Biocept Inc   1,017,926.72 $ 43.771  Million 43 
Lifevantage Corp  1,007,946.19 $ 224.772  Million 223 
Bionexus Gene Lab Corp   1,000,215.11 $ 19.004  Million 19 
Collegium Pharmaceutical Inc   978,784.87 $ 414.026  Million 423 
Bluebird Bio Inc   974,455.65 $ 241.665  Million 248 
Cytomx Therapeutics Inc   967,246.38 $ 66.740  Million 69 
Endo International Plc  955,505.97 $ 2,800.588  Million 2,931 
Ontrak Inc   954,048.08 $ 99.221  Million 104 
Incyte Corporation  950,391.35 $ 2,702.913  Million 2,844 
Sangamo Therapeutics Inc   925,323.94 $ 131.396  Million 142 
Exelixis Inc   898,738.45 $ 1,030.853  Million 1,147 
Abbvie Inc   880,614.04 $ 50,195.000  Million 57,000 
Alpha Pro Tech Ltd   875,666.67 $ 107.707  Million 123 
Intercept Pharmaceuticals inc   857,864.00 $ 321.699  Million 375 
Supernus Pharmaceuticals inc   853,302.15 $ 556.353  Million 652 
Aurinia Pharmaceuticals Inc   851,125.00 $ 108.944  Million 128 
Abiomed Inc   847,522.00 $ 847.522  Million 1,000 
Ngm Biopharmaceuticals Inc   845,790.00 $ 84.579  Million 100 
Jazz Pharmaceuticals Plc  843,052.60 $ 2,436.422  Million 2,890 
Verastem Inc   828,098.04 $ 84.466  Million 102 
Co diagnostics Inc   808,947.82 $ 93.029  Million 115 
Esperion Therapeutics Inc   794,846.94 $ 233.685  Million 294 
Enanta Pharmaceuticals Inc  784,658.33 $ 94.159  Million 120 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.